Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty

1994291 citationsJournal Articlebronze Open Access

Authors

William Weintraub · Emory University

Stephen J. Boccuzzi

J. Larry Klein · Emory University

Andrzej S. Kosinski · Emory University

Spencer B. King · Emory University

Russell J. Ivanhoe · AdventHealth Orlando

John C. Cedarholm · Fawcett Memorial Hospital

Abstract

Treatment with high-dose lovastatin initiated before coronary angioplasty does not prevent or delay the process of restenosis in the first six months after the procedure.

Topics & Keywords

Lipoproteins and Cardiovascular Health Coronary Interventions and Diagnostics Natural Products and Biological Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 331, Issue 20, pp. 1331-1337

DOI: 10.1056/nejm199411173312002

Field-Weighted Citation Impact: 28.95